SI-BONE, Inc.
corporate_fare Company Profile
SI-BONE, Inc. (NASDAQ:SIBN) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 13 items for SIBN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-03, rated 7/10. Across its 13 most recent items scored 7 or higher, the top rating is 8/10, with 9 rated 8 or above. Recent SEC coverage for SIBN spans 10-Q, 8-K, 10-K.
Recent high-impact activity:
- SI-BONE Q3 Revenue Up 14.5% to $55.7M; Operating Cash Flow Turns Positive
- SI-BONE Posts 8-Cent Q3 Loss Per Share
- FDA Clears SI-BONE's iFuse Granite Onyx for Spinal Fusion, Expanding Beyond Pelvis
- SI-BONE Recalls 98 iFuse TORQ Implants Over Sterility Risk; Two Already Implanted
- SI-BONE Q2 Revenue Climbs 15%, Loss Narrows; CEO Adopts 10b5-1 Plan
Financial Snapshot
Short Interest & Short Volume
6.84 days to coverFINRA reported short interest of 4,526,148 shares in SIBN as of the October 30, 2026 settlement, a 3.8% decrease from the prior period — about 6.8 days to cover at its recent average daily volume. On November 20, 2026, 38.5% of SIBN volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.